A Pharmaceutical Procurement Conference By the Industry, For the Industry

Day Two - 29th February 2012

08:15 Registration and coffee No session description available.

09:00 Chair’s opening remarks Trevor Jones, Director, Allergan Inc Trevor Jones Director, Allergan Inc Prof Trevor M Jones CBE PhD Hon DSc FRSC FRSM FPS FKC Hon FRCP FFPM FBPharmacolS. FCPP.Professor Jones is a Director of Allergan Inc (USA) , Sigma Tau (Italy), SciClone Pharmaceuticals Inc (USA) ,ReNeuron plc, Synexus Ltd and VeronaPharma plc.. Between 1987-94 he was a main board director of The Wellcome Foundation, where he was responsible for R&D including the development of AZT [read more]

09:10 Strategic and practical advice to retaining talent in offices in China to support business growth Ashley Readshaw, CPO, AstraZeneca • How AstraZeneca is building its employer brand to attract the best people in dynamic emerging markets • How to bridge cultural differences to motivate teams with diverse goals and aspirations • How we are leveraging our reputation to develop a talent pipeline to support its long-term emerging market investment strategy Ashley Readshaw CPO, AstraZeneca Ashley is a CIMA qualified accountant and has held senior executive level finance and supply chain positions in the pharmaceuticals and fast moving consumer goods industries with companies including: Mars, GSK and Pharmacia. He joined AstraZeneca in 2008 as VP Finance for Operations from Bristol-Myers Squibb, where he had managed 14 pharmaceutical manufacturing plants in North and South America. H [read more]

09:50 EXPERT CPO INTERVIEW CIRCLE: The Roadmap for Procurement 2020 - what will the pharmaceutical and biotech companies of the future look like? Ashley Readshaw, CPO, AstraZeneca Jean-Philippe Collin, VP, Chief Procurement Officer, Sanofi-Aventis Richard Pompe, Group R&D Purchasing Director, Mylan Inc • With a changing regulatory environment, increased outsourcing and off-shoring, movements into emerging markets, increased activity in taking over biotech companies – what will the pharmaceutical and biotech companies of the future look like? • What impact will these have on the procurement process? How will market opportunities and risk be evaluated? What will the new business models look like? • What will be the central themes to pharma procurement strategies in 2020? • What should you do to stay best in class in terms of people, technology and processes within pharmaceutical procurement (direct and indirect)? Ashley Readshaw CPO, AstraZeneca Ashley is a CIMA qualified accountant and has held senior executive level finance and supply chain positions in the pharmaceuticals and fast moving consumer goods industries with companies including: Mars, GSK and Pharmacia. He joined AstraZeneca in 2008 as VP Finance for Operations from Bristol-Myers Squibb, where he had managed 14 pharmaceutical manufacturing plants in North and South America. H [read more] Jean-Philippe Collin VP, Chief Procurement Officer, Sanofi-Aventis Chief Procurement Officer at Sanofi since April 2010, Jean-Philippe COLLIN (55, French, graduated from Supelec, PhD Physics) started his career at IBM . He has held several executive positions in the areas of technology, quality and Procurement at IBM, Valeo & Thomson. In 2004, he joined PSA Peugeot Citroën as Procurement Director, and subsequently served as CEO of the Two-wheels D [read more] Richard Pompe Group R&D Purchasing Director, Mylan Inc Richard Pompe has worked in the Pharmaceutical Industry for more than 16 years with experience covering a number of functional areas. His early experiences in the industry encompass working in the sales, marketing and training departments of Roche Pharmaceuticals and Merck-Lipha. After nearly 10 years Richard moved into the contract research arena in business development working for one of the lea [read more]

10:20 Tomorrow is already here. Are we ready? Ed Stapor, Partner, CEO Europe, Havas Worldwide Health • Where is the future of healthcare marketing going - an agency’s perspective • With regulatory changes facing the pharma profession, how can we realign client and agency expectations • Measuring the ‘value’ that is provided by agencies – how can you use analytics to do this? • What is the ‘ideal’ agency model that will provide the most value to clients? Ed Stapor Partner, CEO Europe, Havas Worldwide Health Ed has spent 18 years with Euro RSCG Life; started in Canada, on to California, then New York, and now based in London, responsible for all Euro RSCG Life and Health4Brands European operations. He counts his three proudest achievements as; winning the Viagra account in 1997, given the publicity and anticipation before launch, leading the worldwide team under the single agency model for launching/r [read more]

11:00 Morning coffee and networking No session description available.

11:30 OUT-OF-INDUSTRY CASE STUDY: Procurement best practice in the Oil and Gas sector – transferrable learnings from a similarly heavily regulated industry Stan Goense, VP Contracting and Procurement, Shell • How is procurement structured within the organisation and the oil and gas sector • Which categories are outsourced within direct and indirect and to what extent • What impact does regulation have on procurement within the oil and gas sector • How does procurement add value to the top line in a heavily regulated industry • Which best practice can be transferred to pharma procurement Stan Goense VP Contracting and Procurement, Shell

12:00 PANEL DISCUSSION: Pharmaceutical supply chain risk management Jean-Philippe Collin, VP, Chief Procurement Officer, Sanofi-Aventis Gautam Singh, Chief Executive, The Smart Cube Alejandro Basso, Purchasing Corporate Director, Almirall • Ensuring supplier continuity - especially after the Japan incident –when second sourcing may not be an option • What sort of contingency plans should be in place to reduce associated risks in direct and indirect procurement? Jean-Philippe Collin VP, Chief Procurement Officer, Sanofi-Aventis Chief Procurement Officer at Sanofi since April 2010, Jean-Philippe COLLIN (55, French, graduated from Supelec, PhD Physics) started his career at IBM . He has held several executive positions in the areas of technology, quality and Procurement at IBM, Valeo & Thomson. In 2004, he joined PSA Peugeot Citroën as Procurement Director, and subsequently served as CEO of the Two-wheels D [read more] Gautam Singh Chief Executive, The Smart Cube Gautam brings 20 years of experience in supply chain and procurement as he manages and builds The Smart Cube to be the leading provider of customised market intelligence solutions for procurement organisations. Very much a hands on, practical procurement professional, Gautam has built an organisation that understands and engages the procurement professional and generates relevant insights to suppo [read more] Alejandro Basso Purchasing Corporate Director, Almirall Alejandro is the Purchasing Corporate Director at Almirall, based in the company’s headquarters located in Barcelona. He has eighteen years experience in the pharmaceutical industry and has always been linked to the Procurement function. He joined Almirall in 2003, coming from a smaller Pharma company, starting as a International Purchasing manager with responsibility over Direct and Indirect expe [read more]

12:30 A system to manage your flexible labor suppliers? How does that fit in the procurement picture? Silvester de Keijzer, Senior Vice President Business Development, Beeline International • Does you flexible labor suppliers consume the biggest portion of indirect spend? • How can you stay in control of this spend?  • How can you reduce cost in this category beyond the current standard methods?  • What needs to be done to implement a Vendor Management System? Silvester de Keijzer Senior Vice President Business Development, Beeline International Silvester de Keijzer is Senior Vice President Business Development EMEA at Beeline International based in Zurich.He joined Beeline in 2011 with more than 22 years international experience within HR consulting and outsourcing. Seasoned operationally orientated leader with multi-industry experience, building, strengthening and leading functions within Business/HR Consulting, Outplacement, Recruitmen [read more]

13:10 Lunch and networking

STREAM A: Direct ProcurementSTREAM B: Indirect Procurement 14:15 Stream Chair: Opening remarks - Duncan Brock, Customer Relations Director, CIPS STREAM A: Direct Procurement 14:15 Stream Chair: Opening remarks - Trevor Jones, Director, Allergan Inc STREAM B: Indirect Procurement

STREAM A:Direct ProcurementSTREAM B:Indirect Procurement 14:20 Can procurement meet the pharma skills challenge? STREAM A:Direct Procurement Mark Hollison, Director of Procurement, Napp Pharmaceuticals • Defining core procurement skills, knowledge and attributes –competency profiling, creating development frameworks and building a balanced team • Skills focus for indirect vs direct procurement – what’s different, so what skills help to differentiate? • Marketplace for procurement professionals – look externally or develop from within? Mark Hollison Director of Procurement, Napp Pharmaceuticals Mark Hollison is Director of Procurement at Napp Pharmaceuticals Limited – A privately owned business which specialises in technology based medicines traditionally in the relief of moderate to severe pain but now diversifying into new therapeutic areas including those of oncology and respiratory disease. The role encompasses that of both ‘direct and indirect’ procurement activity and as part of th [read more] 14:20 Network design and optimisation STREAM B:Indirect Procurement Claudia Knowlton-Chike, GM, Global Logistics, GE Healthcare • Understanding the trade-offs and what you are optimising for • Strategizing - gathering the right data, with the right talent and the right model • Operationalising – after modeling, building the business cases and operating mechanisms to deploy • Execution – deploying the design – change management and sustaining the change Claudia Knowlton-Chike GM, Global Logistics, GE Healthcare Claudia Knowlton-Chike is the GM of Global Logistics at GE Healthcare. Claudia’s responsibilities include transportation, warehousing, packaging, trade compliance, import, export and network optimization for all regions and businesses. Claudia has transformed the Global Logistics function for GE Healthcare – building domain expertise and deploying an aggressive 3-year strategy to simplify the netw [read more]

14:55 AFTERNOON KEYNOTE: Managing the spend whilst procuring pharma insurance – how to gain the appropriate level of cover for the complex range of associated risks Imtiaz Naqui, Head of Purchasing, Teva Pharmaceuticals Imtiaz Naqui Head of Purchasing, Teva Pharmaceuticals

15:30 Chair's closing remarks and afternoon tea and coffee No session description available.